Latest news with #TilrayBrands
Yahoo
5 days ago
- Business
- Yahoo
Beverages, Alcohol, and Tobacco Stocks Q1 In Review: Tilray (NASDAQ:TLRY) Vs Peers
As the Q1 earnings season comes to a close, it's time to take stock of this quarter's best and worst performers in the beverages, alcohol, and tobacco industry, including Tilray (NASDAQ:TLRY) and its peers. These companies' performance is influenced by brand strength, marketing strategies, and shifts in consumer preferences. Changing consumption patterns are particularly relevant and can be seen in the rise of cannabis, craft beer, and vaping or the steady decline of soda and cigarettes. Companies that spend on innovation to meet consumers where they are with regards to trends can reap huge demand benefits while those who ignore trends can see stagnant volumes. Finally, with the advent of the social media, the cost of starting a brand from scratch is much lower, meaning that new entrants can chip away at the market shares of established players. The 15 beverages, alcohol, and tobacco stocks we track reported a mixed Q1. As a group, revenues missed analysts' consensus estimates by 0.5%. In light of this news, share prices of the companies have held steady as they are up 2.2% on average since the latest earnings results. Founded in 2013, Tilray Brands (NASDAQ:TLRY) engages in cannabis research, cultivation, and distribution, offering a range of medical and recreational cannabis products, hemp-based foods, and alcoholic beverages. Tilray reported revenues of $185.8 million, down 1.4% year on year. This print fell short of analysts' expectations by 10.1%. Overall, it was a slower quarter for the company with a significant miss of analysts' EBITDA and gross margin estimates. Irwin D. Simon, Chairman and Chief Executive Officer of Tilray Brands, stated, "Tilray Brands is shaping the future of consumer markets with a robust global infrastructure spanning the beverage, cannabis, and wellness industries. We are meeting the needs of today's consumers while preparing for the demands of tomorrow. In the third quarter, we prioritized sales quality and revenue, protected margins, reduced debt, and improved our capital structure. With a strong balance sheet and a clear vision for the future, Tilray is well positioned to capitalize on emerging opportunities and ensure long-term success.' Tilray delivered the weakest performance against analyst estimates and weakest full-year guidance update of the whole group. The stock is down 21.3% since reporting and currently trades at $0.46. Read our full report on Tilray here, it's free. With a primary focus on soda but also a presence in energy drinks and teas, Zevia (NYSE:ZVIA) is a better-for-you beverage company. Zevia reported revenues of $38.02 million, down 2% year on year, outperforming analysts' expectations by 1.7%. The business had a very strong quarter with a solid beat of analysts' EPS estimates and an impressive beat of analysts' EBITDA estimates. The market seems happy with the results as the stock is up 35.3% since reporting. It currently trades at $2.76. Is now the time to buy Zevia? Access our full analysis of the earnings results here, it's free. Sporting an impressive roster of iconic beer brands, Molson Coors (NYSE:TAP) is a global brewing giant with a rich history dating back more than two centuries. Molson Coors reported revenues of $2.30 billion, down 11.3% year on year, falling short of analysts' expectations by 5.1%. It was a disappointing quarter as it posted a significant miss of analysts' adjusted operating income estimates. As expected, the stock is down 6.1% since the results and currently trades at $53.34. Read our full analysis of Molson Coors's results here. A pioneer and behemoth in carbonated soft drinks, Coca-Cola (NYSE:KO) is a storied beverage company best known for its flagship soda. Coca-Cola reported revenues of $11.22 billion, flat year on year. This result topped analysts' expectations by 0.6%. Aside from that, it was a satisfactory quarter as it also recorded a decent beat of analysts' organic revenue estimates but EBITDA in line with analysts' estimates. The stock is flat since reporting and currently trades at $71.15. Read our full, actionable report on Coca-Cola here, it's free. Known for its flavorful beverages challenging the status quo, Boston Beer (NYSE:SAM) is a pioneer in craft brewing and a symbol of American innovation in the alcoholic beverage industry. Boston Beer reported revenues of $453.9 million, up 6.5% year on year. This number surpassed analysts' expectations by 4.1%. It was a very strong quarter as it also logged an impressive beat of analysts' EPS estimates and a solid beat of analysts' EBITDA estimates. Boston Beer scored the biggest analyst estimates beat among its peers. The stock is down 5.6% since reporting and currently trades at $228.55. Read our full, actionable report on Boston Beer here, it's free. Thanks to the Fed's rate hikes in 2022 and 2023, inflation has been on a steady path downward, easing back toward that 2% sweet spot. Fortunately (miraculously to some), all this tightening didn't send the economy tumbling into a recession, so here we are, cautiously celebrating a soft landing. The cherry on top? Recent rate cuts (half a point in September 2024, a quarter in November) have propped up markets, especially after Trump's November win lit a fire under major indices and sent them to all-time highs. However, there's still plenty to ponder — tariffs, corporate tax cuts, and what 2025 might hold for the economy. Want to invest in winners with rock-solid fundamentals? Check out our Strong Momentum Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate. Join Paid Stock Investor Research Help us make StockStory more helpful to investors like yourself. Join our paid user research session and receive a $50 Amazon gift card for your opinions. Sign up here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
20-05-2025
- Business
- Associated Press
The $600B Beverage Shift: Why Function Is Outpacing Flavor
Equity Insider News Commentary Issued on behalf of Safety Shot, Inc. VANCOUVER, B.C., May 20, 2025 /PRNewswire/ -- Equity Insider News Commentary – In the U.S. and abroad, analysts report that consumer interest in 'boosted' drinks—those promising anything from gut health to stress relief—is not only rising but redefining how wellness is consumed. RBC's Nik Modi recently told an industry forum that functionality and wellness will dominate beverage growth over the next decade, driven by aging populations and rising demand for convenience. Meanwhile, according to Research and Markets the global market is forecast to swell to nearly $175 billion by 2030, with women and APAC consumers leading the charge toward cleaner labels, fortified ingredients, and plant-based formats. Amid this shift, several public companies are positioning themselves for upside—including Safety Shot, Inc. (NASDAQ: SHOT), Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY), The Hain Celestial Group, Inc. (NASDAQ: HAIN), Zevia PBC (NYSE: ZVIA), and The Vita Coco Company, Inc. (NASDAQ: COCO). Beverages aren't just about quenching thirst anymore —they're becoming the delivery system of choice for health-conscious consumers. Analysts at Insightace Analytic are even more optimistic than Research and Markets, forecasting that the global functional beverage market could reach $618.8 billion by 2034, expanding at a steady 9.4% compound annual growth rate as drinks and supplements continue to converge into one of the most dynamic categories in consumer goods. Safety Shot, Inc. (NASDAQ: SHOT) is gaining early momentum in the functional beverage space, capturing interest with a patented formulation designed to support the body's natural ability to reduce blood alcohol content. The company is tapping into a fast-growing market segment where wellness meets nightlife, offering a solution built for modern consumers who want to enjoy their evening without paying the price tomorrow. At the heart of the product lineup is Sure Shot®—a first-of-its-kind beverage that has clinically shown in human trials that it works with the body's metabolism to help lower BAC and promote clearer, more energized mornings. With strong consumer appeal, growing retail visibility, and a strategic IP portfolio, Safety Shot is carving out a unique lane in the evolving better-for-you beverage category. Safety Shot's late-2023 rebrand and launch on Amazon made an immediate impact, with multiple sellouts signaling strong early traction. That momentum has continued into 2024, as more consumers look for functional options that fit into active social lifestyles. The company is finding its lane in a category that sits between energy drinks and next-day wellness support—an emerging sweet spot for performance-minded buyers. Backed by clinical research, the brand is building confidence with a product that does more than just hydrate. A peer-reviewed human study published in the Journal of Nutrition and Dietary Supplements reported that Sure Shot helped lower both blood and breath alcohol markers compared to placebo. Participants also noted feeling clearer and more alert—feedback that aligns with the product's positioning around smarter self-care and next-morning readiness. Availability has expanded rapidly, with Sure Shot now offered through Amazon, and retail names like 7-Eleven, Albertsons, Vons, and GoPuff. A newly launched stick-pack version enhances portability and consumer trial, while also improving merchandising flexibility and margin profile. On the IP front, Safety Shot recently secured an additional patent covering elements of its formulation—further strengthening its position in the wellness beverage landscape. This added layer of protection supports long-term brand value and provides a competitive moat as the category continues to evolve. To accelerate growth, the company has signed a definitive agreement to acquire Yerbaé Brands Corp., a plant-based energy drink company with an established retail footprint and over $12 million in trailing revenue. The move expands Safety Shot's reach into adjacent functional beverage markets, offering cross-category synergy and access to a broader health-conscious audience. As it scales, the company is evolving its marketing strategy —transitioning from early influencer efforts to targeted, grassroots brand-building. New retail activations and partnerships within the beverage and alcohol ecosystem are designed to drive trial, increase product visibility, and reinforce brand relevance at the point of consumption. Safety Shot has also initiated a spinout of its Caring Brands subsidiary, allocating 2 million shares to existing shareholders as part of a value-add initiative. Initially offered for a limited time, the program has been extended into the second half of 2025, giving more investors the opportunity to participate in the potential upside. With expanding distribution, clinical research, growing intellectual property, and a strategic acquisition in motion, Safety Shot is beginning to transition from early mover to category contender. Its focus remains on building a defensible brand that aligns with the modern consumer's pursuit of energy, clarity, and control. CONTINUED… Read this and more news for Safety Shot at: Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) latest expansion play targets both cannabis beverage fans and edible-curious consumers with the nationwide launch of XMG Atomic Sours. The brand is leveraging sour nostalgia to introduce a differentiated sensory experience in both drink and gummy formats. It also marks High Park Holdings' formal entry into the cannabis gummy space, broadening Tilray's platform. The release comes as functional beverage crossover products continue to gain momentum across retail channels. The Hain Celestial Group, Inc. (NASDAQ: HAIN) continues to lean into functional wellness trends through its beverage brands, which include plant-based and herbal offerings spanning global markets. Although beverage sales dipped this quarter, the company attributed the softness to non-dairy shifts in Europe and a delayed start to hot tea season. Management emphasized that innovation and portfolio discipline will drive recovery and growth. As market momentum builds around health-first consumption, Hain remains positioned to capitalize on structural tailwinds across the category. 'Going forward, we are focused on five key drivers for improving value: simplifying our business and reducing overhead spending, accelerating renovation and innovation in our brands, implementing strategic revenue growth management and pricing actions, driving operational productivity and working capital reduction, and strengthening our digital capabilities,' said Alison Lewis, Interim President and CEO of Hain Celestial. 'The opportunity ahead of us now is to unlock the full value of our business through focused and disciplined execution.' Zevia PBC (NYSE: ZVIA) reported first-quarter results that beat expectations on multiple fronts, including a record 50.1% gross margin and improved adjusted EBITDA. The company's flagship zero-sugar beverages (containing stevia) are gaining traction through new product formats and an aggressive marketing push, including a top-performing variety pack at Walmart. 'We are pleased to have delivered net sales at the high end of our guidance while meaningfully exceeding our adjusted EBITDA expectations for the first quarter,' said Amy Taylor, President and CEO of Zevia. 'Both our innovation and marketing strategies are yielding strong response.' The Vita Coco Company, Inc. (NASDAQ: COCO) is adding some summer flair to its functional beverage lineup with the launch of Piña Colada Coconut Juice with pulp. 'We wanted to capture the classic vacation feeling of a Piña Colada, but make it more accessible for everyday enjoyment, no blender or beach required,' said Jane Prior, Chief Marketing Officer of The Vita Coco Company. 'With summer just weeks away, Piña Colada Coconut Juice is the perfect addition to your favorite summer traditions.' The new flavor blends pineapple and coconut water to deliver hydration and nostalgia in a single can, tapping into the growing consumer trend toward flavorful, health-conscious alternatives. This expansion reflects the brand's continued strategy of pairing tropical indulgence with clean-label functionality. Article Sources: CONTACT: Equity Insider [email protected] (604) 265-2873 DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. This article is being distributed by Equity Insider on behalf of Media Corp. ('BAY'). Equity Insider is a wholly-owned entity of Market IQ Media Group Inc. ('MIQ'). MIQ has not been paid a fee for the distribution of this article, but the owner of MIQ also co-owns BAY. BAY has been paid a fee for Safety Shot Inc. advertising and digital media from Creative Digital Media Group ('CDMG') (fifty five thousand dollars USD for a three month contract subject to the terms and conditions of the agreement from the company direct). There may be 3rd parties who may have shares of Safety Shot Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ/BAY does not own any shares of Safety Shot Inc. but reserve the right to buy and sell, and will buy and sell shares of Safety Shot Inc. at any time without any further notice commencing immediately and ongoing. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material, including this article, which is disseminated by MIQ has been approved on behalf of Safety Shot Inc. by CDMG; this is a paid advertisement, we currently own shares of Safety Shot Inc. and will buy and sell shares of the company in the open market, or through private placements, and/or other investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. View original content to download multimedia: SOURCE Equity Insider
Yahoo
17-05-2025
- Business
- Yahoo
Tilray Brands (NasdaqGS:TLRY) Plans Reverse Stock Split
Tilray Brands recently announced plans for a reverse stock split to align its share structure with similar-sized companies and ensure compliance with Nasdaq's listing requirements. Simultaneously, the launch of their new beverage line, Cruisies, appears to have generated positive market reception. These developments may have supported the company's share price rise of 16% over the past week, outpacing the broader market's 5% increase. The company's focus on streamlining operations and expanding its product offerings potentially contributed added confidence among investors, enhancing overall shareholder returns during this period. Tilray Brands has 3 possible red flags we think you should know about. Uncover the next big thing with financially sound penny stocks that balance risk and reward. The announcement of a reverse stock split and new product line, Cruisies, may provide Tilray Brands with some near-term share price support. However, examining the longer-term performance reveals a different story, with the company experiencing a 75% total return decline over the past year, indicating significant challenges remain. Compared to the broader market's positive returns and the US Pharmaceuticals industry's 9.9% decline last year, Tilray's performance highlights its relative struggles amidst sector trends. The company's ongoing initiatives, like SKU rationalization and international expansions, could influence revenue growth forecasts, which are projected to rise at a rate slower than the market. Despite this, Tilray's negative earnings underscore the difficulty in adjusting to competitive pressures and macroeconomic conditions, with no forecasted profitability in the near term. Given the current share price of US$0.46 and a consensus price target of US$1.29, there remains a substantial gap, reflecting the market's skepticism about Tilray's ability to meet these projections in the prevailing landscape. The stock's recent price adjustment may not yet fully align with analyst expectations, indicating persistent uncertainties. Our valuation report here indicates Tilray Brands may be undervalued. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NasdaqGS:TLRY. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
17-05-2025
- Business
- Yahoo
Tilray Brands (NasdaqGS:TLRY) Plans Reverse Stock Split
Tilray Brands recently announced plans for a reverse stock split to align its share structure with similar-sized companies and ensure compliance with Nasdaq's listing requirements. Simultaneously, the launch of their new beverage line, Cruisies, appears to have generated positive market reception. These developments may have supported the company's share price rise of 16% over the past week, outpacing the broader market's 5% increase. The company's focus on streamlining operations and expanding its product offerings potentially contributed added confidence among investors, enhancing overall shareholder returns during this period. Tilray Brands has 3 possible red flags we think you should know about. Uncover the next big thing with financially sound penny stocks that balance risk and reward. The announcement of a reverse stock split and new product line, Cruisies, may provide Tilray Brands with some near-term share price support. However, examining the longer-term performance reveals a different story, with the company experiencing a 75% total return decline over the past year, indicating significant challenges remain. Compared to the broader market's positive returns and the US Pharmaceuticals industry's 9.9% decline last year, Tilray's performance highlights its relative struggles amidst sector trends. The company's ongoing initiatives, like SKU rationalization and international expansions, could influence revenue growth forecasts, which are projected to rise at a rate slower than the market. Despite this, Tilray's negative earnings underscore the difficulty in adjusting to competitive pressures and macroeconomic conditions, with no forecasted profitability in the near term. Given the current share price of US$0.46 and a consensus price target of US$1.29, there remains a substantial gap, reflecting the market's skepticism about Tilray's ability to meet these projections in the prevailing landscape. The stock's recent price adjustment may not yet fully align with analyst expectations, indicating persistent uncertainties. Our valuation report here indicates Tilray Brands may be undervalued. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NasdaqGS:TLRY. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error while retrieving data Sign in to access your portfolio Error while retrieving data
Hamilton Spectator
14-05-2025
- Business
- Hamilton Spectator
Tilray Brands Announces the Launch of XMG Atomic Sours: New THC Beverages and Edibles
TORONTO, May 14, 2025 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, is excited to announce that its wholly-owned subsidiary, High Park Holdings Ltd., is launching XMG Atomic Sours, a new line of cannabis beverages and gummies that redefine the sour experience. XMG Atomic Sours includes two cannabis-infused drinks, Cherry Blasted Lime and Foggy Peaches, and two cannabis-infused gummies, Very Berry Rocket and Cherry Blasted Lime, all crafted to provide consumers with nostalgic sour flavours. XMG Atomic Sours beverages, including Cherry Blasted Lime and Foggy Peaches, offer nostalgic super sour flavors. Each beverage contains 10mg THC, 10mg CBG, and Guarana extract, providing 30mg of naturally occurring caffeine. These beverages are fast-acting due to nano-emulsified THCA diamonds. The XMG Atomic Sours Gummies, available in Very Berry Rocket and Cherry Blasted Lime flavors, mark the brand's entry into the edibles market. This expansion diversifies the brands' product portfolio and caters to emerging consumer preferences. Each gummy is shaped like a nostalgic 'key' and comprises 10mg of nano-emulsified THC and 10mg of CBG. These gummies deliver an intensely sour experience and are crafted using plant-based pectin. XMG Atomic Sours are now available nationwide at select retailers. To find XMG's most recent thirst quenchers and key-shaped gummies and to keep up with the latest news from XMG, follow @findyourXMG on Instagram. About Tilray Brands Tilray Brands, Inc. ('Tilray') (Nasdaq: TLRY; TSX: TLRY) is a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries with operations in Canada, the United States, Europe, Australia, and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray's mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy, wellness and create memorable experiences. Tilray's unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages. For more information on Tilray Brands, visit and follow @Tilray. The content above is on behalf of Aphria Inc., High Park Holdings Ltd., as licensed producers. Forward-Looking Statements Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, 'forward-looking statements') under Canadian and U.S. securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the 'safe harbor' created by those sections and other applicable laws. Forward-looking statements can be identified by words such as 'forecast,' 'future,' 'should,' 'could,' 'enable,' 'potential,' 'contemplate,' 'believe,' 'anticipate,' 'estimate,' 'plan,' 'expect,' 'intend,' 'may,' 'project,' 'will,' 'would' and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws. For more information Media Contact: news@ Investor Contact: investors@ A photo accompanying this announcement is available at
